EBI, a provider of implantable bone growth devices, has bought Xstim, the bone‑healing division of Precision Medical Products in Irving, Texas. The acquisition adds lumbar spinal‑fusion recovery technology to EBI’s lineup. No purchase price was disclosed; the deal closes under Avista Healthcare Partners. The move follows EBI’s recent push to broaden its footprint beyond implantable devices.

Xstim’s non‑invasive approach uses electrical stimulation to speed bone consolidation, complementing EBI’s implantable solutions. Integrating the platforms lets EBI offer clinicians a broader therapeutic spectrum and supports hospitals’ cost‑containment goals by providing a single vendor for implantable and external therapies. The combined offering could lift EBI’s share in a growing orthopedic device market, and hospitals value the solution for reducing procedure times and post‑operative complications.

The transaction widens EBI’s pipeline without diluting its bone‑regeneration focus, creating cross‑selling chances to hospitals and spine specialists. Investors will watch how quickly EBI folds Xstim’s tech into its portfolio and whether the joint offering drives higher revenues. Early integration milestones target a joint product launch by year‑end, giving EBI a timed edge over rivals in the near term for market share.